These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1679062)

  • 1. Prophylactic antiparkinson drug use: I. Initial prophylaxis and prevention of extrapyramidal side effects.
    Lavin MR; Rifkin A
    J Clin Pharmacol; 1991 Aug; 31(8):763-8. PubMed ID: 1679062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic antiparkinson drug use: II. Withdrawal after long-term maintenance therapy.
    Lavin MR; Rifkin A
    J Clin Pharmacol; 1991 Aug; 31(8):769-77. PubMed ID: 1679063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of antiparkinson agents in preventing antipsychotic-induced extrapyramidal symptoms.
    Murphy JE; Stewart RB
    Am J Hosp Pharm; 1979 May; 36(5):641-4. PubMed ID: 36755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
    Sramek JJ; Simpson GM; Morrison RL; Heiser JF
    J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms.
    Bezchlibnyk-Butler KZ; Remington GJ
    Can J Psychiatry; 1994 Mar; 39(2):74-84. PubMed ID: 7908605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current status of our knowledge of the neurotropic side effects of neuroleptic drugs].
    Sabbatini F; Pinessi L; Gentile S; De Mattei M; Portaleone P
    Minerva Psichiatr; 1983; 24(4):145-53. PubMed ID: 6145083
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylaxis of antipsychotic-induced extrapyramidal side effects in east Indians: cultural practice or biological necessity?
    Dhavale HS; Pinto C; Dass J; Nayak A; Kedare J; Kamat M; Dewan M
    J Psychiatr Pract; 2004 May; 10(3):200-2. PubMed ID: 15330229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating extrapyramidal reactions: some current issues.
    Gelenberg AJ
    J Clin Psychiatry; 1987 Sep; 48 Suppl():24-7. PubMed ID: 2887554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Algorithms for the treatment of acute side effects induced by neuroleptics.
    Kusumi I; Koyama T
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S19-22. PubMed ID: 10560893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of neuroleptic-induced extrapyramidal symptoms to predict future vulnerability to side effects.
    Keepers GA; Casey DE
    Am J Psychiatry; 1991 Jan; 148(1):85-9. PubMed ID: 1670616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced extrapyramidal side-effects in Egyptian schizophrenic patients.
    Okasha A; El Okbi H; Sadek A; Lotiaf F; Ashour AM
    Egypt J Psychiatry; 1979 Oct; 2(2):191-7. PubMed ID: 45368
    [No Abstract]   [Full Text] [Related]  

  • 12. Dexetimide: an effective drug for the control of extrapyramidal symptoms induced by pipothiazine palmitate.
    Dom R; Van Lommel R; Baro F
    Acta Psychiatr Scand; 1973; 49(5):563-9. PubMed ID: 4148581
    [No Abstract]   [Full Text] [Related]  

  • 13. Gradual withdrawal of antiparkinson medication in chronic schizophrenics: any better than the abrupt?
    Manos N; Gkiouzepas J; Tzotzoras T; Tzanetoglou A
    J Nerv Ment Dis; 1981 Oct; 169(10):659-61. PubMed ID: 6116743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug induced extrapyramidal effects--a review.
    Coleman JH; Hayes PE
    Dis Nerv Syst; 1975 Oct; 36(10):591-3. PubMed ID: 1100334
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonneuroleptic etiologies of extrapyramidal symptoms.
    Blair DT; Dauner A
    Clin Nurse Spec; 1993 Jul; 7(4):225-31. PubMed ID: 8102320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of extrapyramidal adverse effects in neuroleptic therapy].
    Malm U
    Nord Psykiatr Tidsskr; 1972; 26(6):348-50. PubMed ID: 4634569
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic drug use in a family-practice center.
    Holt RJ; Gaskins JD
    Am J Hosp Pharm; 1981 Nov; 38(11):1716-9. PubMed ID: 6118063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic drug side effects: their relationship to dose.
    Kane JM
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):16-21. PubMed ID: 2859276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapyramidal reactions in adolescents treated with high-potency antipsychotics.
    Chiles JA
    Am J Psychiatry; 1978 Feb; 135(2):239-40. PubMed ID: 23686
    [No Abstract]   [Full Text] [Related]  

  • 20. Is maintenance antiparkinsonian treatment necessary?
    Comaty JE; Janicak PG; Rajaratnam J; Sharma RP; Baker D; Davis JM
    Psychopharmacol Bull; 1990; 26(2):267-70. PubMed ID: 1978373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.